TIGIT and COVID-19: With regard to COVID-19, Hsieh et al. reported that SARS-CoV-2 induced the overexpression of CD155 on infected cells, which binds to its receptor TIGIT on NK cells, resulting in decreased immune responses and viral clearance (76).